HR 6213, the Heat Workforce Standards Act of 2025, prohibits the U.S. Department of Labor from finalizing, implementing, or enforcing OSHA's proposed "Heat Injury and Illness Prevention" standard (published August 30, 2024). This bill directly blocks the specific regulatory proposal targeting heat safety in both outdoor and indoor work settings. It does not create new requirements or affect workers; it solely prevents the implementation of the existing OSHA proposal. The bill is procedural, focusing on halting a regulatory action rather than establishing new policy.
This bill names the Department of Veterans Affairs multispecialty clinic at 1263 Cobb Parkway NW in Marietta, Georgia, as the "Colonel Michael H. Boyce Department of Veterans Affairs Multispecialty Clinic." It is a ceremonial resolution with no policy changes or funding impacts - it solely updates the facility's official designation in government records. The clinic itself remains unchanged, and the bill does not alter services, funding, or operations for veterans.
The AADAPT Act reauthorizes and expands Project ECHO grants to improve Alzheimer’s and dementia care through technology-enabled training. It specifically funds grants for healthcare providers in rural, frontier, or medically underserved areas to enhance early diagnosis, quality care, and provider retention for dementia patients. The bill authorizes $1 million annually (2027-2032) for these dementia-focused training programs, requiring funds to supplement - not replace - existing resources. This directly supports primary care providers licensed to serve underserved communities, using collaborative online learning to address care gaps.
HR 3029, the Nucleic Acid Standards for Biosecurity Act, directs the National Institute of Standards and Technology (NIST) to develop new screening standards for synthetic DNA and RNA production to prevent misuse. It requires NIST to research improved testing accuracy, security protocols for sequence databases, and technical guidance for screening tools, with a stakeholder consortium including industry and researchers to set priorities. The bill authorizes $5 million annually (2026-2030) for NIST to carry out this work and mandates a report to Congress within 18 months of the first consortium meeting. This directly affects biotechnology companies, research institutions, and labs producing synthetic genetic materials by establishing new biosecurity screening requirements.
HR 2821, the FDA Modernization Act 3.0, requires the FDA to update regulatory language within one year of enactment. It directs the agency to replace all references to "animal tests" with "nonclinical tests" in 22 specific sections of the Code of Federal Regulations related to drug development and approval processes. The bill also adds a definition for "nonclinical test" into relevant FDA regulations to align with prior legislative changes. This update applies directly to pharmaceutical manufacturers and FDA reviewers who follow these regulatory guidelines during drug development. The changes aim to modernize terminology without altering current testing requirements.
HR 2715, the *Destruction of Hazardous Imports Act*, expands the authority to destroy imported goods that pose public health risks. It amends the Federal Food, Drug, and Cosmetic Act to allow the Secretary of Health and Human Services to order the destruction of any refused import (not just drugs or devices) if it presents a significant health concern. The bill also prohibits the unauthorized movement, sale, or export of such refused goods. These changes apply to importers of hazardous refused articles 180 days after enactment, with the FDA required to finalize implementing regulations within 90 days.
HR 2306 extends the Adams Memorial Commission's authority until 2032 and authorizes $50 million in federal funds for the memorial, requiring a 1:1 non-federal match and limiting administrative costs to 4% of federal funds. It updates location rules to allow the memorial within a designated area mapped by the Commission. The bill primarily affects the Adams Memorial Commission and entities contributing to the memorial's funding. It makes no new policy changes but adjusts procedural timelines and funding requirements for an existing commemorative project.
The FORMULA Act of 2026 requires the U.S. Food and Drug Administration to set strict limits on contaminants in infant formula, including heavy metals, microplastics, and synthetic pesticides. Manufacturers must test their products to meet these new standards and keep records of their testing for at least two years after the formula's shelf life expires. The law also mandates that the FDA report annually to Congress on any violations and the progress made in reducing contaminant levels in the domestic supply chain. These regulations will take effect 180 days after the bill is signed into law.
The Judicial Integrity Act amends federal law to clarify which judges and Supreme Court justices must recuse themselves from cases involving personal financial interests. It requires that any exemptions from these conflict-of-interest rules be established through a formal regulation issued by the Judicial Conference of the United States, which must include public notice and a comment period. This change ensures that decisions about whether a financial interest is too small to matter are made transparently rather than through individual waivers. The bill directly affects all federal judges and Supreme Court justices by tightening the standards for when they can participate in cases where they have a financial stake.
The Justice is BLIND Act of 2026 requires federal judges, including justices, magistrate judges, and bankruptcy judges, along with their spouses and dependent children, to place specific financial investments into qualified blind trusts within 90 days of taking office or enactment. This rule applies to securities, commodities, and derivatives but excludes widely held mutual funds, U.S. Treasury bonds, and income earned by spouses or children from their own jobs. The bill also mandates that these judges publicly attest to the establishment of the trust or confirm they hold no covered financial interests, with these reports made available online. Additionally, the law prohibits judges from dissolving or controlling these trusts for 180 days after they leave their judicial positions to prevent immediate conflicts of interest.
The BRRRRT Act of 2026 restricts the U.S. Department of Defense from retiring, divesting, or storing A-10 aircraft in a way that reduces the total inventory below the level needed to sustain operations through fiscal year 2033. To comply, the Air Force must maintain a minimum fleet of 126 planes organized into specific units dedicated to close air support and combat search and rescue missions. The bill also mandates that the Air Force preserve retired aircraft in recoverable condition, prohibits using them for spare parts, and requires a detailed plan to restore any training or maintenance capacity that was cut in anticipation of retirement. Additionally, the legislation bars the removal of A-10 training functions at Davis-Monthan Air Force Base and Nellis Air Force Base unless specific conditions are met, while requiring the Air Force to submit regular reports on fleet sustainment and preservation efforts.
This bill expands the Freedom of Information Act to require federal courts to release specific records upon public request. It mandates the disclosure of attorney disciplinary actions, complaints against judges, meeting minutes, jury selection forms, and performance reports, while explicitly excluding information related to ongoing cases. The legislation also requires that released data be in a machine-readable format and authorizes funding to establish an office within the Administrative Office of the United States Courts to manage these new requirements.
